![Thomas Madden](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Madden
Vorstandsvorsitzender bei Acuitas Therapeutics, Inc.
Aktive Positionen von Thomas Madden
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Acuitas Therapeutics, Inc.
![]() Acuitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Acuitas Therapeutics is a private biotechnology company based in Vancouver, Canada that specializes in developing delivery systems for nucleic acid therapeutics based on lipid nanoparticles. The Canadian company partners with pharmaceutical and biotechnology companies, academic institutes, and non-governmental organizations to advance nucleic acid therapeutics into clinical trials and the marketplace. Acuitas Therapeutics has agreements in place with several partners to use its proprietary lipid nanotechnology in the development of COVID-19 vaccines, including Pfizer/BioNTech for Comirnaty®. The CEO of the company is Thomas Madden. | Vorstandsvorsitzender | - | - |
Präsident | - | - |
Karriereverlauf von Thomas Madden
Statistik
International
Kanada | 2 |
Operativ
Chief Executive Officer | 1 |
President | 1 |
Sektoral
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Acuitas Therapeutics, Inc.
![]() Acuitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Acuitas Therapeutics is a private biotechnology company based in Vancouver, Canada that specializes in developing delivery systems for nucleic acid therapeutics based on lipid nanoparticles. The Canadian company partners with pharmaceutical and biotechnology companies, academic institutes, and non-governmental organizations to advance nucleic acid therapeutics into clinical trials and the marketplace. Acuitas Therapeutics has agreements in place with several partners to use its proprietary lipid nanotechnology in the development of COVID-19 vaccines, including Pfizer/BioNTech for Comirnaty®. The CEO of the company is Thomas Madden. | Commercial Services |
- Börse
- Insiders
- Thomas Madden
- Erfahrung